WebbCNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. WebbReata Pharmaceuticals (NASDAQ: RETA) was a clinical-stage biopharmaceutical company until the U.S. Food and Drug Administration (FDA) approved its first treatment on Feb. …
The top 10 takeover targets in biopharma Fierce Biotech
Webb1 aug. 2024 · Reata is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the... Webb12 apr. 2024 · Reata Pharmaceuticals, Inc. (RETA) NasdaqGM - NasdaqGM Real-time price. Currency in USD Add to watchlist 48.83 +6.14 (+14.38%) At close: 04:00PM EST 49.74 +0.91 (+1.86%) After hours: 07:56PM... the amazing spider man 2 game mods
The Best of Benzinga Benzinga
WebbRETA interactive stock chart Reata Pharmaceuticals, Inc. stock - Yahoo Finance Back Reata Pharmaceuticals, Inc. (RETA) Add to watchlist NasdaqGM - NasdaqGM Real-time price. Currency in... Webb13 apr. 2024 · Reata Pharmaceuticals, Inc. ist ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Identifizierung, Entwicklung und Vermarktung von Therapien konzentriert. Das Unternehmen konzentriert sich auf niedermolekulare Therapeutika mit Wirkmechanismen zur Behandlung von schweren, lebensbedrohlichen … WebbReata Pharmaceuticals, Inc. (RETA) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Add to watchlist 93.98 +1.29 (+1.39%) At close: 04:00PM EDT 94.00 +0.02 (+0.02%) After hours: 07:57PM EDT... the game satara